Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11359018 Anti-PD-1 antibodies and compositions

Patent 11359018 was granted and assigned to Symphogen on June, 2022 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Current Assignee

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

113590180

Patent Inventor Names

Camilla Frohlich0

Vikram Kjoller Bhatia0

Torben Gjetting0

Thomas Bouquin0

Monika Gad0

Klaus Koefoed0

Johan Lantto0

Gunther Roland Galler0

Date of Patent

June 14, 2022

Patent Application Number

164619570

Date Filed

November 17, 2017

Patent Citations

‌

US Patent 11034765 Anti-PD-1 antibodies and compositions

Patent Citations Received

‌

US Patent 11939380 Combination therapies targeting PD-1, TIM-3, and LAG-3

Patent Primary Examiner

CPC Code

This invention relates to anti-PD-1 antibodies and methods of using them in treating diseases and conditions related to PD-lactivity, e.g., cancer.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11359018 Anti-PD-1 antibodies and compositions

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API